Sustainable antimicrobial modified chitosan and its nanoparticles hydrogels: Synthesis and characterization

被引:47
作者
Ahmed, Marwa ElS [1 ]
Mohamed, Hemat M. [1 ]
Mohamed, Mansoura, I [1 ]
Kandile, Nadia G. [1 ]
机构
[1] Ain Shams Univ, Fac Women Art Sci & Educ, Chem Dept, Cairo 11757, Egypt
关键词
Chitosan; Nanoparticles; Antimicrobialactivity; Heterocyclic compound; SCHIFF-BASES; ANTIBACTERIAL ACTIVITY; CROSS-LINKING; CIPROFLOXACIN; ANTIFUNGAL; DERIVATIVES; INFECTION; ACETATE; ACID; FTIR;
D O I
10.1016/j.ijbiomac.2020.08.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The target of the present study is the development of sustainable chitosan and chitosan nanoparticles-based heterocyclic compound hydrogels with antimicrobial properties. Sustainable antimicrobial new modified chitosan hydrogel (CS-3) was synthesized by the reaction of chitosan (CS) with 2-([4-[(1, 3-dioxoisoindolin-2-ylimino) methyl] phenyl] methyleneamino) isoindoline-1, 3-dione (3) via ring opening of cyclic imide moiety in compound (3). However, the modified chitosan nanoparticles hydrogel (CS-3 NPs) were prepared in-situ by an ionotropic gelation technique using sodium tripolyphosphate (TPP) as the cross-linking agent. The prepared hydrogels were characterized by FTIR, SEM, TEM, TGA, DSC and elemental analysis. The hydrogels were tested versus eight pathogenic strains of Gram +ve and Gram -ve bacteria and two fungi. The results revealed that hydrogels (CS-3) and (CS-3 NPs) showed higher antimicrobial activities than virgin (CS) and (CS-NPs). However, hydrogel (CS-3 NPs) showed the highest Minimal Inhibitory Concentration (MIC) and Minimal Bactericidal Concentration (MBC) especially with Gram +ve bacteria (S. pyogenes) at 19.5 and 39 mu g/ml compared to the standard antibiotic Ciprofloxacin at 19 and 38 mu g/ml respectively. (c) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:1388 / 1397
页数:10
相关论文
共 65 条
[1]   Preparation, characterization and antibacterial properties of cyanoethylchitosan/cellulose acetate polymer blended films [J].
Abou-Zeid, N. Y. ;
Waly, A. I. ;
Kandile, N. G. ;
Rushdy, A. A. ;
El-Sheikh, M. A. ;
Ibrahim, H. M. .
CARBOHYDRATE POLYMERS, 2011, 84 (01) :223-230
[2]  
Anand M., 2018, Front. Lab. Med, V2, P72, DOI [10.1016/j.flm.2018.07.003, DOI 10.1016/J.FLM.2018.07.003]
[3]   Physicochemical and morphological properties of size-controlled chitosan-tripolyphosphate nanoparticles [J].
Antoniou, John ;
Liu, Fei ;
Majeed, Hamid ;
Qi, Jing ;
Yokoyama, Wallace ;
Zhong, Fang .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2015, 465 :137-146
[4]  
Bangun H., 2018, J Appl Pharm Sci, V8, P147, DOI [10.7324/JAPS.2018.81217, DOI 10.7324/JAPS.2018.81217]
[5]  
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[6]   Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives [J].
Bhandari, Shashikant V. ;
Bothara, Kailash G. ;
Raut, Mayuresh K. ;
Patil, Ajit A. ;
Sarkate, Aniket P. ;
Mokale, Vinod J. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (04) :1822-1831
[7]   ORAL CIPROFLOXACIN TREATMENT FOR SALMONELLA-TYPHIMURIUM INFECTION OF NORMAL AND IMMUNOCOMPROMISED MICE [J].
BRUNNER, H ;
ZEILER, HJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (01) :57-62
[8]   CIPROFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
CAMPOLIRICHARDS, DM ;
MONK, JP ;
PRICE, A ;
BENFIELD, P ;
TODD, PA ;
WARD, A .
DRUGS, 1988, 35 (04) :373-447
[9]  
Cárdenas G, 2004, J CHIL CHEM SOC, V49, P291, DOI 10.4067/S0717-97072004000400005
[10]   Preliminary studies of rosmarinic acid microencapsulation with chitosan and modified chitosan for topical delivery [J].
Casanova, F. ;
Estevinho, B. N. ;
Santos, L. .
POWDER TECHNOLOGY, 2016, 297 :44-49